Caffeine as a Substitute for Schedule II Stimulants in Hyperkinetic Children
ROBERT C. SCHNACKENBERG M.D.1
1 Chief, Child and Adolescent Service, William S. Hall Psychiatric Institute, Box 119, Columbia, S.C. 29202
Children being treated with methylphenidate or dextroamphetamine for minimal brain dysfunction syndrome and subsequent hyperkinetic impulse disorder may develop annoying side effects. A pilot study substituting caffeine, in the form of two cups of regular coffee a day, suggests that caffeine may be a suitable alternative to Schedule II drugs. The author points out the advantages of treatment with caffeine and suggests some specific aspects for further studies in this area.
